Utilizing Nanorobots to Diagnose the World’s Deadliest diseases.
Recent advances in nanorobotics have enabled early detection of cancers with just a blood sample, but this takes 2 weeks. Cancer diagnoses using scans and tissue biopsy are slow, expensive and risky for patients. With the advancement of liquid biopsy, patients can be screened or diagnosed with just a blood sample, but this technique is still slow and expensive as it relies on PCR and sequencing.
We have a point-of-care solution that is 10× cheaper and 100× faster: Our nanorobots are added to blood samples. When they capture a cancer biomarker they light up, allowing point-of-care testing. As there is no need for high capital expenditure, our nanorobots are 10 times cheaper. The whole process is also more than 100 times faster – a matter of one or two hours rather than weeks – as there is no need for complex lab protocols which require bioinformaticians to analyze the data.
How does nanorobot work?
1. Cancer DNA is in blood.
2. The nanorobot is inserted into the blood sample.
3. Nanorobots distinguishes specific cancer mutation.
4. After 1 – 2 hours it lights up if it found a mutation.
5. Thanks to AI, we design new nanorobots for new cancer mutations.